Liposomal prostaglandin E1 can reduce inflammatory factors and the incidence of adverse cardiac events for percutaneous coronary intervention

LIANG Wen-hua; et al

doi:10.13406/j.cnki.cyxb.2010.03.012

您当前的位置：

首页 >

文章列表页 >

Liposomal prostaglandin E1 can reduce inflammatory factors and the incidence of adverse cardiac events for percutaneous coronary intervention

更新时间：2024-01-17

- Liposomal prostaglandin E1 can reduce inflammatory factors and the incidence of adverse cardiac events for percutaneous coronary intervention
- Journal of Chongqing Medical University Vol. 35, Issue 3, Pages: 427-429(2010)
- 作者机构：
  
  1. 湖南省衡阳市解放军第169医院内三科
  2. 张家港奥洋医院心内科
  3. 第二军医大学附属长海医院
  4. 中南大学湘雅二医院心内科
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2010.03.012
  CLC： R541.4
- Published：2010，
扫描看全文
[1]梁文华,丁继军,林飞,唐亮,李解贵,彭寒林,周炜.脂质体携载前列腺素E1对冠脉介入治疗后炎症因子的影响[J].重庆医科大学学报,2010,35(03):427-429.

LIANG Wen-hua, et al. Liposomal prostaglandin E1 can reduce inflammatory factors and the incidence of adverse cardiac events for percutaneous coronary intervention. [J]. Journal of Chongqing Medical University 35(3):427-429(2010)
[1]梁文华,丁继军,林飞,唐亮,李解贵,彭寒林,周炜.脂质体携载前列腺素E1对冠脉介入治疗后炎症因子的影响[J].重庆医科大学学报,2010,35(03):427-429. DOI： 10.13406/j.cnki.cyxb.2010.03.012.

LIANG Wen-hua, et al. Liposomal prostaglandin E1 can reduce inflammatory factors and the incidence of adverse cardiac events for percutaneous coronary intervention. [J]. Journal of Chongqing Medical University 35(3):427-429(2010) DOI： 10.13406/j.cnki.cyxb.2010.03.012.

摘要

目的:观察早期使用脂质载体前列腺素E1对经皮冠状动脉介入治疗（Percutaneous coronary intervention

PCI）患者血浆炎症因子的影响。方法:74例行PCI治疗的患者随机分成实验组和对照组。前者入选后给予PGE120μg+生理盐水40ml静脉注射

Bid×3d

对照组患者则不给。其余基础治疗措施相同。于PCI术前1d、术后2d、术后5d、术后4周查CRP、IL-6、TNF-α

并观察观察术后60d内早期心脏事件发生情况。结果:两组患者经PCI治疗后1d

CRP水平有所上升

与同组术前1d相比有显著差异（P<0.05）

但与对照组相比均未见有差异（P>0.05）。术后5d～4周

实验组的水平已较术前有所下降（P<0.05）

对照组较术前亦有下降（P<0.05）

并且实验组CRP的水平较对照组下降更为明显（P>0.05）。炎症因子IL-6、TNF-α和CRP表现出一样的变化趋势。并且

用药期间2组未出现不良反应

安全性良好。结论:在PCI术后早期CRP、IL-6和TNF-α可有升高

但早期应用Lipo-PGE1后

可有效抑制炎症因子水平。

Abstract

Objective:To observe the inflammatory factors for early use of lipid carriers prostaglandin E1 on percutaneous coronary intervention(PCI).Method:74 patients treated with PCI were randomly divided into experimental and control groups.PGE1 20μg + 40 ml normal saline intravenously

Bid × 3 d

were used in experimental groups

but not to the patients in the control group.The basis treatment was the same.CRP

IL-6

TNF-α were checked in the pre-operative 1 d

after 2 d

after 5 d

after 4 w

and after 60 d

the early incidence of cardiac events were observed.Results:CRP levels in every patients for two groups increased at 1 d(P<0.05)

CRP level in the experimental group compared with the control group were not different(P>0.05).After 5 d～4 w

CRP level in the experimental group were declined than 1 d(P <0.05)

also dropped than the control group(P <0.05)

and the level of CRP in the experimental group decreased more than the control group(P>0.05).Inflammatory factor IL-6

TNF-α and CRP showed the same trend.Conclusions:CRP

IL-6 and TNF-α may have increased in the early stage of post-PCI

and the use of Lipo-PGE1 may be effective in containing the level of inflammatory factors.

关键词

前列腺素E1皮冠状动脉介入治疗炎症因子

Keywords

Prostaglandin E1Percutaneous coronary interventioninflammatory factor

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Jiedu-Shengji ointment regulates GSK-3β/β-catenin to reduce inflammatory response to promote chronic wound healing in diabetic SD rats

Value of inflammatory，pyroptosis，and ferroptosis biomarkers in the treatment and prognosis of bladder cancer

The perioperative application of prostaglandin E₁ for patients with rheumatic heart diease associated with pulmonary hypertension

Effects of recombinant human elafin on the expression of inflammatory factors and NF-κB p65 protein in neonatal mice with bronchopulmonary dysplasia induced by chronic hyperoxia

Expression and significance of transcription factor activator protein-2 in Buerger’s disease

Related Author

Zhou Zhongzhi

Hong Kaiqi

Yuan Zhongheng

Chen Li

Ding Yarong

Wang Wei

Wang Yumeng

Zheng Shixu

Related Institution

School of Integrated Traditional Chinese and Western Medicine，Hunan University of Chinese Medicine

Medical College，Hunan University of Chinese Medicine

Department of Burn & Skin Ulcer Plastic Surgery， The First Affiliated Hospital of Hunan University of Chinese Medicine

Department of Urology,Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University

Department of Urology,The Second Hospital,University of South China

⁰